Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05329077 · ClinicalTrials.gov registry record · NA
Pulsenmore ES Device, Efficacy and Safety Assessment
A NA study, sponsored by PulseNmore.
- Completed
- Registry status
- NA
- Development phase
- 188
- Enrollment target
NCT05329077 is a NA study that has completed, run by PulseNmore. The registered enrollment target is 188 participants.
The verdict
NCT05329077, a NA study, has completed, sponsored by PulseNmore.
- COMPLETED
- Registry status
- NA
- Development phase
- 188 participants
- Enrollment target
Study Summary
This is a multicenter, prospective, investigational device study designed to evaluate: The safety, feasibility, and accuracy of the device, when used by pregnant individuals
Interventions
- DEVICE Pulsenmore ES home ultrasound device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2022-04-14 |
| Est. Completion | 2023-11-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05329077
The ClinicalTrials.gov registry entry for NCT05329077 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 188 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PulseNmore, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pulsenmore ES home ultrasound device is the first listed.
NCT05329077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05329077 about?
NCT05329077 is a clinical study titled "Pulsenmore ES Device, Efficacy and Safety Assessment". This is a multicenter, prospective, investigational device study designed to evaluate: The safety, feasibility, and accuracy of the device, when used by pregnant individuals
What is the current status of trial NCT05329077?
This trial is currently completed. It is a NA study. The enrollment target is 188 participants. The study started on 2022-04-14. Estimated completion is 2023-11-11.
What interventions are being tested in trial NCT05329077?
The interventions under investigation include: Pulsenmore ES home ultrasound device (DEVICE).
Who is sponsoring clinical trial NCT05329077?
This trial is sponsored by PulseNmore, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.